Physician profile
Hope E Barnum
NPI 1609307537
$4,032.57
in general payments reported to CMS, 2019-2025
38 companies · $541 in 2025
The $541 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $218 · 2021: $1,261 · 2022: $909 · 2023: $667 · 2024: $437 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,644.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $777.57 | 2021-2025 | Vraylar, Qulipta |
| Glaxosmithkline, LLC. | $564.67 | 2020-2025 | Trelegy Ellipta, Shingrix, Nucala |
| Novo Nordisk INC | $436.63 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $357.54 | 2020-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $283.63 | 2020-2025 | Farxiga, Breztri, Airsupra |
| Esperion Therapeutics, INC. | $215.13 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $124.86 | 2025 | Voquezna |
| Amarin Pharma, INC. | $112.91 | 2020-2022 | |
| Lilly USA, LLC | $108.89 | 2021-2025 | Jardiance, Mounjaro |
| Janssen Pharmaceuticals, INC | $95.61 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $67.78 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $66.54 | 2020-2024 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $64.63 | 2024-2025 | Eliquis, Camzyos |
| Ibsa Pharma INC. | $63.67 | 2021 | |
| Amgen INC. | $61.75 | 2021-2025 | Repatha, Otezla |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hope Barnum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.